Success Story: EB1A Approved Despite RFE! We Helped a Postdoctoral Fellow Secure Success with Premium Processing Service
Client’s Testimonial:
"North American Immigration Law Group was a great choice for me. They know what they are doing and were very helpful throughout the process. Their guidance was accurate, professional, and clear."
On August 6th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Computational Drug Discovery and Toxicology (Approval Notice).
General Field: Computational Drug Discovery and Toxicology
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: India
State of Residence at the Time of Filing: Louisiana
Approval Notice Date: August 6th, 2026
Processing Time: 3 months, 20 days (Premium Processing Requested)
Case Summary:
Pioneering Research in Small-Molecule Inhibitors and AI Modeling
The client is an established expert in computational drug discovery and toxicology and stands out as one of the few leading specialists in cheminformatics. In their current role at a major U.S. research institution, the client develops artificial intelligence-driven predictive models and web applications to support early-stage drug discovery and chemical toxicity assessment.
Strategic Framing: How the Petition Demonstrated Major Significance
Rather than assuming high metrics alone would satisfy the stringent EB-1A standard, our petition meticulously analyzed how an adjudicator should interpret each accomplishment:
- Sustained Scientific Productivity: The client authored 25 peer-reviewed journal articles (including 8 first-authored and 3 co-first-authored publications), 2 first-authored conference abstracts, and 2 book chapters (1 first-authored).
- Demonstrated Citatory Influence: The client’s published body of work has accumulated 738 citations from independent researchers in over 64 countries.
- Peer Review Authority: The client has been invited to judge the work of peers at least 20 times for prestigious international periodicals.
Funding from National and International Agencies: The petition highlighted that the client's research endeavors have been awarded competitive funding from prestigious organizations, including the National Institutes of Health (NIH) and major national research foundations.
Endorsements from Industry Leaders
To reinforce the objective quantitative evidence, the petition included 2 letters of recommendation from internationally renowned experts in the field, including an Independent Advisory Opinion from a leading scientist who had never collaborated directly with the client but recognized their major contributions through published literature.
The Result
By combining rigorous bibliometric benchmarking with a clear narrative of extraordinary achievement, the petition satisfied both parts of the Kazarian framework. USCIS approved this EB-1A petition under direct Premium Processing, confirming the client's status as a premier scientist at the very top of computational drug discovery and toxicology. We celebrate this outcome and look forward to the client's ongoing contributions.